Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


18.02.2019

2 Am Fam Physician
1 Appl Microbiol Biotechnol
1 Biomed Eng Online
1 BMC Cancer
1 Cochrane Database Syst Rev
1 Enferm Clin
1 Eur J Obstet Gynecol Reprod Biol
1 Front Public Health
2 Gene
1 Ginekol Pol
1 Gynecol Oncol
1 Insights Imaging
1 Int Immunopharmacol
1 Int J Gynecol Cancer
1 Int J Mol Sci
1 J Cell Biochem
1 J Comput Biol
2 J Gynecol Oncol
1 J Immunother Cancer
3 J Low Genit Tract Dis
2 JAMA
1 Med Sci Monit
1 Medicine (Baltimore)
1 Nuklearmedizin
1 Obstet Gynecol
1 Obstet Gynecol Surv
1 Oncol Res
1 Oncol Rev
1 Papillomavirus Res
1 Phys Med
2 PLoS One
1 Prev Med
1 Sante Publique
1 Sci Rep
1 Strahlenther Onkol
1 Tunis Med
1 Vaccine
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban
5 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Fam Physician

  1. NGO-METZGER Q, Adsul P
    Screening for Cervical Cancer.
    Am Fam Physician. 2019;99:253-254.
    PubMed     Text format    


  2. Screening for Cervical Cancer: Recommendation Statement.
    Am Fam Physician. 2019;99:Online.
    PubMed     Text format    


    Appl Microbiol Biotechnol

  3. WANG L, Du W, Zhu S, Jiang P, et al
    A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.
    Appl Microbiol Biotechnol. 2019 Feb 15. pii: 10.1007/s00253-019-09655.
    PubMed     Text format     Abstract available


    Biomed Eng Online

  4. WILLIAM W, Ware A, Basaza-Ejiri AH, Obungoloch J, et al
    A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
    Biomed Eng Online. 2019;18:16.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. COUVREUR K, Naert E, De Jaeghere E, Tummers P, et al
    Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.
    BMC Cancer. 2018;18:1101.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  6. KIETPEERAKOOL C, Aue-Aungkul A, Galaal K, Ngamjarus C, et al
    Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa).
    Cochrane Database Syst Rev. 2019;2:CD012828.
    PubMed     Text format     Abstract available


    Enferm Clin

  7. UTAMI S, Purwani W
    Increasing mothers' knowledge of cervical cancer risk through peer group health education with "PinKa" method.
    Enferm Clin. 2019 Feb 7. pii: S1130-8621(19)30018.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  8. QUEIROZ ACM, Fabri V, Mantoan H, Sanches SM, et al
    Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;235:6-12.
    PubMed     Text format     Abstract available


    Front Public Health

  9. MORRIS BJ, Hankins CA, Banerjee J, Lumbers ER, et al
    Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
    Front Public Health. 2019;7:4.
    PubMed     Text format     Abstract available


    Gene

  10. FENG LL, Shen FR, Zhou JH, Chen YG, et al
    Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Gene. 2019 Feb 7. pii: S0378-1119(19)30075-7. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available

  11. HE Y, Zhao H, Li XM, Yin CH, et al
    Use of mesothelin as a tumor-associated antigen in cervical squamous cell carcinoma.
    Gene. 2019;690:30-37.
    PubMed     Text format     Abstract available


    Ginekol Pol

  12. SNIADECKI M, Wydra DG, Wojtylak S, Wycinka E, et al
    The impact of low volume lymph node metastases and stage migration after pathologic ultrastaging of non-sentinel lymph nodes in early-stage cervical cancer: a study of 54 patients with 4.2 years of follow up.
    Ginekol Pol. 2019;90:20-30.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  13. LIANG J, Wolsiefer K, Zestcott CA, Chase D, et al
    Implicit bias toward cervical cancer: Provider and training differences.
    Gynecol Oncol. 2019 Feb 7. pii: S0090-8258(19)30055.
    PubMed     Text format     Abstract available


    Insights Imaging

  14. OTERO-GARCIA MM, Mesa-Alvarez A, Nikolic O, Blanco-Lobato P, et al
    Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers.
    Insights Imaging. 2019;10:19.
    PubMed     Text format     Abstract available


    Int Immunopharmacol

  15. YANG Y, Che Y, Zhao Y, Wang X, et al
    Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
    Int Immunopharmacol. 2019;69:279-288.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  16. YANG L, Chen H
    Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2019 Feb 9. pii: ijgc-2018-000090.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  17. XIA Y, Xu T, Zhao M, Hua L, et al
    Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Cell Biochem

  18. WU Y, Li H, Wang H, Zhang F, et al
    MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.
    J Cell Biochem. 2019 Feb 12. doi: 10.1002/jcb.28421.
    PubMed     Text format     Abstract available


    J Comput Biol

  19. LIU H, Liu L, Zhu H
    The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    J Comput Biol. 2019 Feb 14. doi: 10.1089/cmb.2018.0241.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  20. BOGANI G, Rossetti D, Ditto A, Martinelli F, et al
    Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery.
    J Gynecol Oncol. 2018 Nov 27. pii: 30.e27. doi: 10.3802/jgo.2019.
    PubMed     Text format     Abstract available

  21. PYEON SY, Hur YJ, Lee JM
    Rethinking the next step after unexpected results associated with minimally invasive radical hysterectomy for early cervical cancer.
    J Gynecol Oncol. 2019 Jan 3. pii: 30.e43. doi: 10.3802/jgo.2019.
    PubMed     Text format    


    J Immunother Cancer

  22. HEEREN AM, Rotman J, Stam AGM, Pocorni N, et al
    Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels.
    J Immunother Cancer. 2019;7:43.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  23. CHEN L, Liu L, Tao X, Guo L, et al
    Risk Factor Analysis of Persistent High-Grade Squamous Intraepithelial Lesion After Loop Electrosurgical Excision Procedure Conization.
    J Low Genit Tract Dis. 2019;23:24-27.
    PubMed     Text format     Abstract available

  24. FERRIS DG, Chen J, Isaac A, Braithwaite E, et al
    Reimbursement Incentives to Improve Adherence to Follow-Up of Cervical Cancer Cytology Screening Results in Peru.
    J Low Genit Tract Dis. 2019 Feb 7. doi: 10.1097/LGT.0000000000000459.
    PubMed     Text format     Abstract available

  25. WILSON E, Janssens S, Ng D, Jolly B, et al
    Trainee Performance in Loop Electrosurgical Excision Procedure (LEEP) After Simulation Training.
    J Low Genit Tract Dis. 2019;23:28-32.
    PubMed     Text format     Abstract available


    JAMA

  26. DICKINSON JA
    Age of Initiation of Cervical Cancer Screening.
    JAMA. 2019;321:611-612.
    PubMed     Text format    

  27. CURRY SJ, Krist AH, Owens DK
    Age of Initiation of Cervical Cancer Screening-Reply.
    JAMA. 2019;321:612.
    PubMed     Text format     Abstract available


    Med Sci Monit

  28. YU J, Zhang J, Zhou L, Li H, et al
    The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cance
    Med Sci Monit. 2019;25:1204-1213.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  29. DOU PH, Zhang DF, Su CH, Zhang XL, et al
    Electrical stimulation on adverse events caused by chemotherapy in patients with cervical cancer: A protocol for a systematic review of randomized controlled trial.
    Medicine (Baltimore). 2019;98:e14609.
    PubMed     Text format     Abstract available


    Nuklearmedizin

  30. CEGLA P, Urbanski B, Burchardt E, Roszak A, et al
    Influence of 18F-FDG-PET/CT on staging of cervical cancer.
    Nuklearmedizin. 2019;58:17-22.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  31. PARRA S, Oden M, Schmeler K, Richards-Kortum R, et al
    Low-Cost Instructional Apparatus to Improve Training for Cervical Cancer Screening and Prevention.
    Obstet Gynecol. 2019 Feb 4. doi: 10.1097/AOG.0000000000003140.
    PubMed     Text format     Abstract available


    Obstet Gynecol Surv

  32. SULLIVAN SA, Stringer E, Van Le L
    A Review of Gynecologic Oncology in the Global Setting: Educating and Training the Next Generation of Women's Health Providers.
    Obstet Gynecol Surv. 2019;74:40-49.
    PubMed     Text format     Abstract available


    Oncol Res

  33. LI J, Liu C, Li D, Wan M, et al
    OLFM4 inhibits epithelial-mesenchymal transition and metastatic potential of cervical cancer cells.
    Oncol Res. 2019 Feb 14. doi: 10.3727/096504018X15399955297355.
    PubMed     Text format     Abstract available


    Oncol Rev

  34. PERGIALIOTIS V, Bellos I, Thomakos N, Haidopoulos D, et al
    Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature.
    Oncol Rev. 2019;13:387.
    PubMed     Text format     Abstract available


    Papillomavirus Res

  35. CLIFFORD GM, Tenet V, Georges D, Alemany L, et al
    Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
    Papillomavirus Res. 2019;7:67-74.
    PubMed     Text format     Abstract available


    Phys Med

  36. JODDA A, Piotrowski T, Urbanski B, Malicki J, et al
    Relations between dose cumulated in organs at risk and treatment based on different image-guidance strategies of cervical cancer.
    Phys Med. 2019;57:183-190.
    PubMed     Text format     Abstract available


    PLoS One

  37. LE GM, Radcliffe K, Lyles C, Lyson HC, et al
    Perceptions of cervical cancer prevention on Twitter uncovered by different sampling strategies.
    PLoS One. 2019;14:e0211931.
    PubMed     Text format     Abstract available

  38. LECONTE BA, Szaniszlo P, Fennewald SM, Lou DI, et al
    Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
    PLoS One. 2018;13:e0203403.
    PubMed     Text format     Abstract available


    Prev Med

  39. RANDALL TC, Sauvaget C, Muwonge R, Trimble EL, et al
    Authors response to Papoutsis and colleagues letter to the editor regarding: Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical canc
    Prev Med. 2019 Feb 10. pii: S0091-7435(19)30027.
    PubMed     Text format    


    Sante Publique

  40. PECCATTE E, Vallee J, Trombert B, Savall A, et al
    [Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.]
    Sante Publique. 2018;30:527-532.
    PubMed     Text format     Abstract available


    Sci Rep

  41. ROSA MN, Evangelista AF, Leal LF, De Oliveira CM, et al
    Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.
    Sci Rep. 2019;9:1913.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  42. POETSCH N, Sturdza A, Aust S, Polterauer S, et al
    The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.
    Strahlenther Onkol. 2019 Feb 8. pii: 10.1007/s00066-019-01430.
    PubMed     Text format     Abstract available


    Tunis Med

  43. YAZGHICH I, Berraho M
    Cervical cancer in the Maghreb country (Morocco - Algeria - Tunisia) : epidemiological, clinical profile and control policy.
    Tunis Med. 2018;96.
    PubMed     Text format     Abstract available


    Vaccine

  44. DEHLENDORFF C, Sparen P, Baldur-Felskov B, Herweijer E, et al
    Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31258.
    PubMed     Text format     Abstract available


    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  45. HU Y, Zeng F
    [Expressions of GPR81, MCT1 and MCT4 in squamous carcinoma and their clinical significance].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:950-956.
    PubMed     Text format     Abstract available


    Zhonghua Zhong Liu Za Zhi

  46. ZHANG J, Wang YC, Yu XD, Tian Y, et al
    [Role of Magnetic Resonance Imaging in distinguishing the origin of adenocarcinoma at the junction of the lower uterine segment and endocervix].
    Zhonghua Zhong Liu Za Zhi. 2018;40:912-916.
    PubMed     Text format     Abstract available

  47. JIANG MY, Feng RM, Wang L, Li TY, et al
    [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Zhonghua Zhong Liu Za Zhi. 2018;40:750-756.
    PubMed     Text format     Abstract available

  48. LIU ZH, Lin W, Wang YY, Wu B, et al
    [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Zhonghua Zhong Liu Za Zhi. 2018;40:757-763.
    PubMed     Text format     Abstract available

  49. ZHANG L, Zhao FH
    [Research progression of prophylactic HPV vaccine application].
    Zhonghua Zhong Liu Za Zhi. 2018;40:724-728.
    PubMed     Text format     Abstract available

  50. TIAN YB, Zhang CT
    [Molecular detection and genotyping of human papillomavirus].
    Zhonghua Zhong Liu Za Zhi. 2018;40:729-735.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: